Sort
50,496 grants matching “lung cancer”
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
$543,820Pau Castel · New York University School Of Medicine · R01 · FY2024 · CA
Nanoscale/Molecular analysis of Fecal Colonocytes for Colorectal Cancer Screening
$543,723Vadim Backman · Northwestern University · R01 · FY2016 · CA
Metarrestin for the Treatment of Pancreatic Cancer
$543,703Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
$543,681Joseph Robert Testa · Research Inst Of Fox Chase Can Ctr · R01 · FY2016 · CA
Spectral Markers for Early Detection of Colon Neoplasia
$543,670Hemant K Roy · Boston Medical Center · U01 · FY2014 · CA
Protein Structure, Stability, and Amyloid Formation
$543,630Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Steroid Hormones, Adipose-cytokines, and Diabetes Risk
$543,626Simin Liu · University Of California Los Angeles · R01 · FY2007 · DK
Serum Antibody Profiling with a Carbohydrate Microarray
$543,615Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
$543,577Susan E Langmore · Boston Medical Center · R01 · FY2008 · CA
Stroger Hospital of Cook County, Department of Surgery,*
$543,572Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2010 · CA
Cancer Immunotherapy by Targeting A2 Adenosine Receptor
$543,566Michail Sitkovsky · Northeastern University · R01 · FY2009 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$543,560Dan R Littman · New York University School Of Medicine · R01 · FY2024 · CA
Lung Cancer Prognosis: FLT PET and DNA Hypermethylation
$543,475Hubert J Vesselle · University Of Washington · R01 · FY2009 · CA
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
$543,470Roland Jurecic · University Of Miami School Of Medicine · R01 · FY2019 · CA
Lead identification and pre-clinical studies on allosteric inhibitors of coagulation factor XIa
$543,375Umesh Ramanlal Desai · Virginia Commonwealth University · R61 · FY2022 · HL
Lead identification and pre-clinical studies on allosteric inhibitors of coagulation factor XIa
$543,375Umesh Ramanlal Desai · Virginia Commonwealth University · R61 · FY2023 · HL
lncRNA regulation of glioblastoma progression and therapeutic resistance
$543,237Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$543,223John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2021 · CA
Analysis of Tumor Dynamics in Progression and Metastasis
$543,220University Of Pennsylvania · U01 · FY2005 · CA
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$543,190Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2022 · CA
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$543,188Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2023 · CA
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
$543,139Dejana K Braithwaite · University Of Florida · R01 · FY2025 · CA
Engineered Nanoformulation for Immune-modulation in Cancer
$543,107Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Venous Thrombosis in Cancer Outpatients: Prevention and Role of Tissue Factor
$543,090Charles W. Francis · University Of Rochester · R01 · FY2012 · HL
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$543,053David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA